Atea Pharmaceuticals, Inc. (AVIR)
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2021
- $351.4M
- Net income
- -$158.3M
- Total assets
- $315.2M
- Market cap
- $340.1M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $180.9M
- Operating income
- -$180.9M
- Income tax
- -$6.2M
- Net income
- -$158.3M
- EPS (basic)
- $-1.94
- EPS (diluted)
- $-1.94
Balance sheet
- Total assets
- $315.2M
- Current assets
- $311.0M
- Total liabilities
- $39.8M
- Current liabilities
- $39.8M
- Shareholders’ equity
- $275.4M
Cash flow
- Operating cash flow
- -$132.0M
- Investing cash flow
- $188.8M
- Financing cash flow
- -$25.7M
- Net cash flow
- $31.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $340.1M
- EPS (diluted)
- $-1.94
- Shares outstanding
- 71.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 30, 2020
Atea Pharmaceuticals, Inc. (AVIR) Stock Price
- Reported a net loss of $158.3M in FY2021.
- Trading 23% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Atea Pharmaceuticals, Inc..
Write a review
News about Atea Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Atea Pharmaceuticals, Inc.: frequently asked questions
Is Atea Pharmaceuticals, Inc. an American company?
Atea Pharmaceuticals, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Atea Pharmaceuticals, Inc. headquartered?
Atea Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts, United States.
Is Atea Pharmaceuticals, Inc. publicly traded?
Yes — Atea Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol AVIR on the NASDAQ.
What does Atea Pharmaceuticals, Inc. do?
Atea Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
